JP2024523559A5 - - Google Patents
Info
- Publication number
- JP2024523559A5 JP2024523559A5 JP2023579554A JP2023579554A JP2024523559A5 JP 2024523559 A5 JP2024523559 A5 JP 2024523559A5 JP 2023579554 A JP2023579554 A JP 2023579554A JP 2023579554 A JP2023579554 A JP 2023579554A JP 2024523559 A5 JP2024523559 A5 JP 2024523559A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- human
- pharmaceutical product
- approximately
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163214521P | 2021-06-24 | 2021-06-24 | |
| US63/214,521 | 2021-06-24 | ||
| US202163290364P | 2021-12-16 | 2021-12-16 | |
| US63/290,364 | 2021-12-16 | ||
| PCT/US2022/073148 WO2022272300A1 (en) | 2021-06-24 | 2022-06-24 | Methods of using aldosterone synthase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523559A JP2024523559A (ja) | 2024-06-28 |
| JP2024523559A5 true JP2024523559A5 (cg-RX-API-DMAC7.html) | 2025-06-23 |
Family
ID=84545863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579554A Pending JP2024523559A (ja) | 2021-06-24 | 2022-06-24 | アルドステロン合成酵素阻害剤を使用する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240277698A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4358959A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523559A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240035483A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2022299103B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023027025A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223211A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309428A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023015121A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022272300A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026521801A (ja) * | 2023-06-29 | 2026-07-01 | アストラゼネカ アイルランド リミテッド | バクスドロスタットの結晶形、並びにその製造方法及びその使用 |
| CN121712504A (zh) * | 2023-07-27 | 2026-03-20 | 矿物疗法公司 | 用洛伦司他及两种或更多种降压药的组合治疗高血压的方法 |
| IL329013A (en) * | 2023-12-15 | 2026-08-01 | Astrazeneca Ireland Ltd | SGLT2 inhibitors and baxadrostat for the treatment of chronic kidney disease and hypertension |
| WO2026120166A1 (en) | 2024-12-06 | 2026-06-11 | AstraZeneca Ireland Limited | Tablet formulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996024358A1 (en) * | 1995-02-10 | 1996-08-15 | G.D. Searle & Co. | Use of low dose amount of spironolactone for treatment of cardiovascular disease |
| AU4866196A (en) * | 1995-02-10 | 1996-08-27 | G.D. Searle & Co. | Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic |
| US20070196510A1 (en) * | 2006-02-17 | 2007-08-23 | Gerber Michael J | Method for treating resistant hypertension |
| CA2832996C (en) * | 2011-04-26 | 2019-05-07 | Merck Sharp & Dohme Corp. | Tricyclic triazole compounds and their use as aldosterone synthase inhibitors |
| US9353081B2 (en) * | 2011-09-23 | 2016-05-31 | Hoffmann-La Roche Inc. | Bicyclic dihydroquinoline-2-one derivatives |
-
2022
- 2022-06-24 JP JP2023579554A patent/JP2024523559A/ja active Pending
- 2022-06-24 WO PCT/US2022/073148 patent/WO2022272300A1/en not_active Ceased
- 2022-06-24 EP EP22829524.2A patent/EP4358959A4/en active Pending
- 2022-06-24 KR KR1020247002601A patent/KR20240035483A/ko active Pending
- 2022-06-24 US US18/569,853 patent/US20240277698A1/en active Pending
- 2022-06-24 BR BR112023027025A patent/BR112023027025A2/pt unknown
- 2022-06-24 AU AU2022299103A patent/AU2022299103B2/en active Active
- 2022-06-24 MX MX2023015121A patent/MX2023015121A/es unknown
- 2022-06-24 CA CA3223211A patent/CA3223211A1/en active Pending
- 2022-06-24 IL IL309428A patent/IL309428A/en unknown
-
2026
- 2026-03-16 AU AU2026201954A patent/AU2026201954A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH06102622B2 (ja) | 肥満の治療 | |
| US20080096832A1 (en) | Method for Improving the Pharmacokinetics of an NNRTI | |
| JP2022536623A (ja) | 肺動脈性肺高血圧症の治療方法 | |
| JP3313714B2 (ja) | 抗虚血薬剤 | |
| JP2022533968A5 (cg-RX-API-DMAC7.html) | ||
| KR20010015918A (ko) | 안면홍조를 감소시키기 위한 플루옥세틴 히드로클로라이드 | |
| JP2024539476A5 (cg-RX-API-DMAC7.html) | ||
| JP2023531930A5 (cg-RX-API-DMAC7.html) | ||
| JP2024525164A5 (cg-RX-API-DMAC7.html) | ||
| JP2000513356A (ja) | エナラプリルとロサルタンの組成物 | |
| JP2008501023A (ja) | 小児患者での癌の治療 | |
| JP2025511403A5 (cg-RX-API-DMAC7.html) | ||
| JP3885135B2 (ja) | C型又は非b非c型肝炎ウイルスによる肝機能異常の改善剤 | |
| JPH09216831A (ja) | 抗ウイルス剤 | |
| JP2008535907A5 (cg-RX-API-DMAC7.html) | ||
| JP4628622B2 (ja) | 冠状動脈移植片血管攣縮の治療または予防方法 | |
| SK284581B6 (sk) | Použitie levosimendanu alebo jeho farmaceuticky prijateľnej soli na výrobu liečiva na liečenie pľúcnej hypertenzie | |
| JP2024527715A5 (cg-RX-API-DMAC7.html) | ||
| JP4965791B2 (ja) | 敗血症性ショックの治療方法 | |
| CN113616651B (zh) | 一种复方降压药物组合物及其应用 | |
| Hart et al. | ACE inhibition versus calcium antagonism in the treatment of mild to moderate hypertension: a multicentre study. Ireland-Netherlands Lisinopril-Nifedipine Study Group | |
| KR20250155479A (ko) | 칸데사르탄, 암로디핀 및 인다파미드를 포함하는 고혈압 예방 또는 치료용 약제학적 복합제제 | |
| Man in’t Veld | The place of isradipine in the treatment of hypertension | |
| WO2025132532A1 (en) | Fixed combination of telmisartan, amlodipine and indapamide for the treatment of hypertension | |
| WO2025221288A1 (en) | Treatment of diseases via administration of buntanetap and an antihypertensive agent |